(18)F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide.
about
Positron Emission Tomography Imaging of Tumor Cell Metabolism and Application to Therapy Response MonitoringBone imaging in prostate cancer: the evolving roles of nuclear medicine and radiologyResponse biomarkers: re-envisioning the approach to tailoring drug therapy for cancerPrognostic value of a computer-aided diagnosis system involving bone scans among men treated with docetaxel for metastatic castration-resistant prostate cancerPrediction of PSA Progression in Castration-Resistant Prostate Cancer Based on Treatment-Associated Change in Tumor Burden Quantified by 18F-Fluorocholine PET/CTDiagnostic imaging to detect and evaluate response to therapy in bone metastases from prostate cancer: current modalities and new horizons.Serial 18F-choline-PET imaging in patients receiving enzalutamide for metastatic castration-resistant prostate cancer: response assessment and imaging biomarkers.PET and PET/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studies.Therapy assessment in prostate cancer using choline and PSMA PET/CT.Progression-free and overall survival in metastatic castration-resistant prostate cancer treated with abiraterone acetate can be predicted with serial C11-acetate PET/CT.Association Between Early PSA Increase and Clinical Outcome in Patients Treated with Enzalutamide for Metastatic Castration Resistant Prostate Cancer.Monitoring for Response to Antineoplastic Drugs: The Potential of a Metabolomic Approach.Preliminary results on response assessment using 68Ga-HBED-CC-PSMA PET/CT in patients with metastatic prostate cancer undergoing docetaxel chemotherapy.Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide.Influence of Androgen Deprivation Therapy on the Uptake of PSMA-Targeted Agents: Emerging Opportunities and Challenges.(11)C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel.Prospective evaluation of [11C]Choline PET/CT in therapy response assessment of standardized docetaxel first-line chemotherapy in patients with advanced castration refractory prostate cancer.PET/CT imaging for evaluating response to therapy in castration-resistant prostate cancer.PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis.
P2860
Q26765882-F3518866-C705-4A75-A103-0501A4EDD3ACQ28071705-1BFD1034-B4D7-4603-B7A6-A20B6F7D5AABQ28074295-36ADF83B-D36F-4C98-86AB-491429E305AFQ35925260-200BD33F-2AE8-498D-9ACC-B33381740DC7Q37496697-F02AB3F4-87D1-4EA6-8771-73DBF4A93311Q38766102-D47B8FB3-2A39-438A-A30A-4F7EAF84F925Q38920663-D88E539B-24F5-4825-95A6-4D7910EEE966Q39242140-15F9879F-2129-483C-BA49-C6090A593A47Q39328036-72C768D5-4FA1-4812-BA54-2F4FB74537F1Q40634245-6F8BE725-584A-424C-A8E9-1542F96E4C71Q40830449-88123DF3-8A79-45CF-A855-43DE94A88889Q47111053-6172E163-2237-405A-A392-4D97AE6F720DQ47399411-A5F51A30-524E-4BD9-9F0C-8EA94B35C0EEQ47645575-3FD76C8C-01D0-4987-A229-D52A52ACD93BQ48116656-FD08F0C1-8FB6-40CB-9980-1980AB419BF2Q48139886-2AEBD431-0865-4EE7-9BAC-4C775F28FCC8Q52982270-729C19A2-23D9-4587-8120-9E9A69A7AEFAQ53772593-1FCFA9D8-9E61-40CD-95ED-6043236448D3Q55020746-04421B32-1BD0-4FC3-9934-F84866392F91
P2860
(18)F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
(18)F-Fluorocholine PET/CT for ...... cer treated with enzalutamide.
@en
type
label
(18)F-Fluorocholine PET/CT for ...... cer treated with enzalutamide.
@en
prefLabel
(18)F-Fluorocholine PET/CT for ...... cer treated with enzalutamide.
@en
P2093
P2860
P50
P1476
(18)F-Fluorocholine PET/CT for ...... ncer treated with enzalutamide
@en
P2093
Andrea Moretti
Cecilia Menna
Dino Amadori
Lorena Rossi
Paola Caroli
Riccardo Galassi
Salvatore Luca Burgio
Ugo De Giorgi
P2860
P2888
P304
P356
10.1007/S00259-015-3042-5
P577
2015-03-26T00:00:00Z